Background People who inject drugs (PWID) are known to be at increased risk of infectious
diseases including bacterial and blood‐borne viral infections. However, there is limited …

Introduction There are currently limited data regarding the clinical and economic
significance of skin and soft tissue infections (SSTI) and bone and joint infections in …

Objective Recent population-level increases in intravenous drug abuse (IVDA) may
contribute to incidence of spinal infection. The aim of this study was to evaluate national …

Background: Pyogenic spine infections (PSIs) are challenging to diagnose and treat. People
who inject drugs (PWID) are at increased risk and contribute to rising PSI incidence …

Skin and soft tissue infections (SSTI) along with bone and joint infections represent a
significant source of morbidity and mortality among people who inject drugs (PWID) …

Object Primary spine infection secondary to intravenous drug abuse (IVDA) is a difficult
clinical entity encountered by spine surgeons and infectious disease specialists. Patients …

Study Design. A prospective comparative analysis of surgically-treated nontuberculous
primary pyogenic infection of the spine (PPIS). Objective. To evaluate and compare the …

Study Design. Retrospective review of the Healthcare Cost and Utilization Project National
Inpatient Sample, 2000 to 2013. Objective. To determine the proportion of spinal epidural …

Introduction Injecting-related bacterial and fungal infections are a common complication
among people who inject drugs (PWID), associated with significant morbidity and mortality …

Injection drug use poses a public health challenge. Clinical experience indicates that people
who inject drugs (PWID) are hospitalized frequently for infectious diseases, but little is …